Indeed, an extensive study of T cell expression of multiple checkpoint proteins found that naïve T cells are controlled by TIM-3 and BTLA, while tumor-infiltrating effector T cells express a wider range of checkpoint molecules depending, to a certain degree, on their anatomical location [162]. The gene discussed is HAVCR2; the disease is neoplasm.